Search results for robert-f-hillary_prevalent_prostate_cancer_(self-report)_fully-adjusted_model
| Author | PMID | Outcome | Exposure | Tissue | Analysis | N | CpG | Location | Gene | Beta | P |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg01032631 | chr9:3526561 | RFX3 | 0.11 | 3.3E-12 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg18147309 | chr17:65362822 | PSMD12 | 0.063 | 5.1E-10 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg13694746 | chr3:106959864 | LOC344595;LOC100302640 | 0.081 | 2.9E-08 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg19342828 | chr4:119974212 | SYNPO2 | -0.062 | 7.8E-08 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg09510924 | chr17:17860297 | TOM1L2 | -0.081 | 9E-08 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg03192775 | chr13:27335151 | GPR12 | 0.05 | 1.2E-07 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg27383534 | chr12:52914297 | KRT5 | -0.057 | 2.2E-07 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg09889065 | chr12:114517855 | - | -0.087 | 3.1E-07 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg16796136 | chr16:5065537 | SEC14L5 | -0.11 | 3.5E-07 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg16152657 | chr2:9243446 | - | -0.12 | 3.6E-07 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg24443629 | chr6:30157507 | TRIM26 | -0.087 | 4.1E-07 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg25557661 | chr20:35928876 | MANBAL | -0.084 | 4.3E-07 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg00969162 | chr21:43547923 | UMODL1 | 0.071 | 5.3E-07 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg22776912 | chr15:81630789 | TMC3 | -0.069 | 5.9E-07 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg09510780 | chr10:104178971 | PSD;FBXL15 | 0.037 | 6.2E-07 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg14918008 | chr6:160669420 | SLC22A2 | -0.071 | 6.7E-07 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg05129817 | chr1:210001399 | C1orf107 | -0.07 | 9.3E-07 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg08812011 | chr12:414066 | KDM5A | -0.044 | 9.9E-07 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg20608759 | chr1:65556231 | - | -0.055 | 1.2E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg06958631 | chr3:81873358 | - | -0.056 | 1.2E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg23302438 | chr1:155177953 | MTX1;THBS3 | -0.075 | 1.4E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg15531272 | chr19:5863479 | - | -0.077 | 1.6E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg01987164 | chr7:140773893 | TMEM178B | 0.059 | 1.6E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg13822256 | chr8:24811266 | NEFL | -0.041 | 1.8E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg21940568 | chr19:52207320 | NCRNA00085 | -0.064 | 3E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg27529935 | chr7:1337377 | - | -0.05 | 3.3E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg13367234 | chr1:17253197 | CROCC | 0.063 | 3.8E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg24836242 | chr6:30908579 | DPCR1 | -0.062 | 4.2E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg23606044 | chr15:84692617 | ADAMTSL3 | 0.053 | 4.4E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg07235343 | chr22:21082278 | PI4KA | -0.036 | 4.7E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg14853282 | chr4:2626239 | FAM193A | 0.059 | 4.8E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg05444742 | chr4:15923011 | - | -0.099 | 5.2E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg07627564 | chr22:27431727 | - | -0.072 | 5.2E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg14007004 | chr19:1758517 | ONECUT3 | 0.032 | 5.4E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg12358061 | chr8:139670789 | COL22A1 | 0.083 | 5.5E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg06466013 | chr11:115591883 | - | -0.11 | 5.5E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg14179164 | chr14:75084315 | - | -0.098 | 5.6E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg02530011 | chr11:17235677 | - | -0.046 | 5.9E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg21230675 | chr8:21943905 | - | -0.062 | 6.2E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg03711137 | chr20:30042291 | - | -0.064 | 6.9E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg05824973 | chr12:52881484 | KRT6A | -0.07 | 7E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg22718431 | chr7:35577163 | - | 0.058 | 7.1E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg13865463 | chr19:9013092 | MUC16 | 0.031 | 7.9E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg11672782 | chr3:38313210 | SLC22A13 | 0.089 | 8.3E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg01750233 | chr8:64498488 | - | -0.083 | 8.3E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg04206190 | chr7:65592179 | CRCP | 0.044 | 8.8E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg21741708 | chr8:143206559 | - | -0.046 | 8.8E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg20669206 | chr2:8727958 | - | -0.064 | 9.6E-06 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg27600082 | chr5:50265907 | LOC100287592 | -0.052 | 1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg22171082 | chr16:14726322 | BFAR | -0.06 | 1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg14603778 | chr12:132896466 | GALNT9 | -0.044 | 1.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg03365278 | chr11:58910470 | FAM111A | 0.035 | 1.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg15108534 | chr1:159823101 | C1orf204 | -0.073 | 1.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg15254063 | chr11:108836469 | - | 0.072 | 1.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg04569202 | chr7:157444423 | PTPRN2 | -0.065 | 1.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg14565332 | chr1:5793761 | - | -0.081 | 1.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg22257680 | chr3:176828875 | TBL1XR1 | 0.054 | 1.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg03205140 | chr10:124133802 | PLEKHA1 | -0.04 | 1.3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg27331500 | chr8:28196022 | PNOC | -0.091 | 1.3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg15382367 | chr12:48348879 | - | -0.082 | 1.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg07817806 | chr16:20344487 | UMOD | -0.073 | 1.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg08976874 | chr11:31885698 | - | 0.04 | 1.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg00652223 | chr16:23200809 | SCNN1G | -0.036 | 1.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg04619194 | chr19:15160254 | CASP14 | -0.052 | 1.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg10612096 | chr2:231865097 | SPATA3 | 0.037 | 1.7E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg25797164 | chr7:100612937 | MUC12 | -0.055 | 1.7E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg25036983 | chr16:54721114 | - | -0.043 | 1.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg08114183 | chr1:24994838 | SRRM1 | -0.062 | 1.9E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg22290832 | chr2:143171775 | - | 0.049 | 2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg09249755 | chr6:41486070 | LINC01276 | -0.064 | 2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg13670099 | chr10:124325615 | DMBT1 | -0.057 | 2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg11280858 | chr12:322214 | SLC6A12 | -0.079 | 2.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg03167620 | chr5:113696147 | - | -0.052 | 2.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg23204461 | chr15:71433547 | THSD4 | 0.063 | 2.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg25217428 | chr1:168148809 | TIPRL | 0.04 | 2.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg15876825 | chr3:11651881 | VGLL4 | -0.041 | 2.3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg09207353 | chr10:126355232 | FAM53B | -0.054 | 2.3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg24487554 | chr8:144163853 | - | -0.039 | 2.3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg06263693 | chr7:129823513 | TMEM209 | 0.1 | 2.3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg16916782 | chr13:113261142 | - | -0.057 | 2.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg22324965 | chr1:40838645 | SMAP2 | -0.073 | 2.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg25801622 | chr12:123596413 | PITPNM2 | -0.096 | 2.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg14474618 | chr1:22536861 | - | -0.046 | 2.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg10168544 | chr1:1010769 | RNF223 | -0.05 | 2.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg05696715 | chr6:26598303 | ABT1 | -0.056 | 2.7E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg27328846 | chr12:59360831 | - | 0.065 | 2.7E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg11213137 | chr15:101846992 | PCSK6 | -0.058 | 2.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg25813508 | chr11:119866650 | - | -0.061 | 2.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg08333580 | chr11:35335229 | SLC1A2 | -0.092 | 2.9E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg00026920 | chr14:101409592 | - | 0.081 | 2.9E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg25889465 | chr17:76203084 | AFMID | -0.075 | 3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg06613586 | chr10:50957837 | OGDHL | -0.063 | 3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg25073179 | chr7:105242291 | - | -0.061 | 3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg23234811 | chr1:204230657 | PLEKHA6 | -0.066 | 3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg25926515 | chr10:70321889 | TET1 | 0.04 | 3.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg09461388 | chr22:46763229 | CELSR1 | -0.039 | 3.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg00365642 | chr2:8456058 | LINC00299 | -0.073 | 3.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg06166802 | chr21:45076717 | HSF2BP | -0.057 | 3.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg08622048 | chr7:127684370 | SND1 | -0.062 | 3.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg25551571 | chr22:22454759 | - | 0.074 | 3.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg12988845 | chr5:4699505 | - | 0.065 | 3.3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg21758126 | chr2:157183291 | NR4A2 | 0.041 | 3.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg08122156 | chr11:7457955 | SYT9 | 0.036 | 3.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg05423100 | chr4:3736042 | - | -0.044 | 3.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg02364564 | chr1:185381462 | - | -0.07 | 3.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg06280592 | chr5:139717988 | HBEGF | 0.073 | 3.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg16438303 | chr16:57496824 | POLR2C | 0.05 | 3.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg16453157 | chr9:126985646 | - | 0.046 | 3.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg22865289 | chr11:12296589 | - | -0.078 | 3.7E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg24870738 | chr1:45097499 | RNF220 | 0.059 | 3.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg03507168 | chr8:17258080 | MTMR7 | -0.052 | 3.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg19548479 | chr17:41363737 | TMEM106A | -0.055 | 3.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg15969359 | chr3:26666163 | LRRC3B | 0.053 | 3.9E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg20835725 | chr22:38200979 | H1F0 | -0.047 | 3.9E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg17696237 | chr21:45160231 | PDXK | -0.049 | 3.9E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg10182243 | chr17:41570164 | DHX8 | 0.057 | 4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg27036376 | chr4:7736057 | SORCS2 | -0.025 | 4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg15657588 | chr6:32075763 | TNXB | -0.099 | 4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg08333839 | chr12:133574150 | ZNF26 | -0.054 | 4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg08370146 | chr11:31849262 | - | 0.046 | 4.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg14094499 | chr8:126780328 | - | -0.053 | 4.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg00877321 | chr11:627612 | SCT | -0.045 | 4.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg26933063 | chr16:25703153 | HS3ST4 | -0.046 | 4.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg18046394 | chr7:29924165 | WIPF3 | -0.042 | 4.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg03571604 | chr17:17875744 | TOM1L2;LRRC48 | 0.065 | 4.3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg12947035 | chr19:41644902 | - | -0.058 | 4.3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg04406898 | chr4:2263822 | MXD4 | 0.058 | 4.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg19328797 | chr5:163340797 | - | 0.044 | 4.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg16497018 | chr10:102133035 | C10orf75 | -0.053 | 4.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg16835531 | chr17:79524882 | NPLOC4 | -0.047 | 4.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg05290820 | chr9:137392877 | - | -0.05 | 4.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg26251909 | chr1:39874809 | KIAA0754;MACF1 | -0.053 | 4.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg03197798 | chr11:26972291 | - | -0.1 | 4.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg16069233 | chr17:6984480 | CLEC10A | 0.042 | 4.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg04616680 | chr18:71576449 | - | -0.065 | 4.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg02728172 | chr1:245740663 | KIF26B | 0.082 | 4.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg04310491 | chr18:34838466 | CELF4 | -0.046 | 5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg09926805 | chr12:32084945 | - | -0.083 | 5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg01719974 | chr5:135334098 | - | -0.08 | 5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg24554944 | chr8:27776888 | SCARA5 | -0.049 | 5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg27404614 | chr18:33717074 | ELP2 | 0.023 | 5.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg00740089 | chr7:29842121 | - | -0.072 | 5.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg03227191 | chr2:70681570 | TGFA | -0.035 | 5.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg27272210 | chr12:9486542 | - | 0.08 | 5.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg18334681 | chr6:132066129 | ENPP3 | -0.048 | 5.3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg02245362 | chr2:23827344 | KLHL29 | -0.055 | 5.3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg18970604 | chr13:26796048 | RNF6 | 0.054 | 5.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg08474852 | chr17:64902963 | - | -0.061 | 5.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg04681669 | chr20:61984613 | CHRNA4 | -0.04 | 5.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg05396212 | chr17:39683705 | KRT19 | 0.07 | 5.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg01548889 | chr16:17173095 | - | -0.038 | 5.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg25179685 | chr8:54154528 | OPRK1 | -0.064 | 5.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg14476058 | chr14:76737725 | RNU6-19P;RNU6-31P | -0.067 | 5.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg16185462 | chr2:239405863 | - | 0.087 | 5.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg16063716 | chr14:105045992 | C14orf180 | -0.063 | 5.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg01960885 | chr18:24765781 | CHST9 | -0.036 | 5.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg02065637 | chr20:61809035 | MIR124-3 | -0.042 | 6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg00221904 | chr4:8136852 | ABLIM2 | -0.071 | 6.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg16787283 | chr14:88507527 | LINC01146 | -0.052 | 6.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg22949034 | chr2:122305305 | CLASP1 | 0.031 | 6.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg22757957 | chr1:91440433 | ZNF644 | -0.087 | 6.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg00797183 | chr4:74368966 | AFM | -0.056 | 6.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg04461058 | chr10:21367869 | NEBL | -0.059 | 6.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg21523093 | chr13:41209950 | FOXO1 | -0.088 | 6.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg27401724 | chr17:43213629 | ACBD4 | -0.09 | 6.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg13420934 | chr6:3088823 | RIPK1 | -0.092 | 6.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg05570707 | chr2:24270316 | C2orf44 | 0.049 | 6.3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg09186897 | chr1:169862509 | SCYL3 | 0.043 | 6.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg01744331 | chr11:2722358 | KCNQ1OT1;KCNQ1 | -0.043 | 6.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg00297741 | chr10:1198879 | - | 0.073 | 6.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg20689197 | chr11:116381756 | - | 0.049 | 6.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg26014538 | chr3:147126763 | ZIC1 | -0.04 | 6.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg16659071 | chr2:208121604 | - | 0.063 | 6.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg13877017 | chr17:18829111 | PRPSAP2 | 0.023 | 6.7E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg05152925 | chr14:45603667 | FKBP3;FANCM | 0.041 | 6.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg22657456 | chr1:11668581 | LOC101929181 | -0.089 | 6.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg15692172 | chr6:170561912 | - | -0.047 | 6.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg24000528 | chr2:177013630 | MIR10B | -0.046 | 6.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg26844633 | chr15:40635904 | - | 0.047 | 6.9E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg23134318 | chr22:25108105 | - | -0.043 | 7E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg07951628 | chr2:47403707 | CALM2 | -0.041 | 7.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg25891078 | chr12:1738035 | WNT5B | 0.078 | 7.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg06658673 | chr20:60035550 | CDH4 | -0.045 | 7.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg03351248 | chr15:100880064 | ADAMTS17 | -0.044 | 7.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg01520578 | chr19:41536777 | - | -0.048 | 7.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg19729237 | chr20:6617097 | - | 0.05 | 7.3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg11910807 | chr17:76802184 | USP36 | -0.074 | 7.3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg08439244 | chr15:91641719 | SV2B | -0.041 | 7.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg08590978 | chr9:130850935 | SLC25A25 | -0.076 | 7.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg22435281 | chr2:55176169 | EML6 | -0.091 | 7.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg05587648 | chr19:4151818 | - | 0.045 | 7.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg13304265 | chr1:36111024 | - | -0.049 | 7.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg09543853 | chr2:47532143 | LOC101927043 | -0.051 | 7.9E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg19248367 | chr11:67141079 | LOC100130987;CLCF1 | -0.053 | 8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg07051847 | chr16:88924003 | GALNS;TRAPPC2L | 0.05 | 8.1E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg25678532 | chr18:20513147 | RBBP8 | 0.038 | 8.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg10631684 | chr12:113795897 | PLBD2 | -0.038 | 8.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg26956245 | chr7:30518972 | NOD1 | -0.038 | 8.2E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg13663116 | chr9:116372034 | - | -0.047 | 8.3E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg26253974 | chr1:213030372 | LQK1;FLVCR1 | -0.042 | 8.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg07635369 | chr19:48216813 | EHD2 | -0.059 | 8.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg08985968 | chr13:101174096 | PCCA | -0.038 | 8.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg09478742 | chr17:43973311 | MAPT;LOC100128977;LOC100130148 | -0.048 | 8.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg08883487 | chr1:23997231 | - | -0.078 | 8.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg00784671 | chr22:46762841 | CELSR1 | -0.022 | 8.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg19533322 | chr10:1595704 | ADARB2 | -0.049 | 8.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg24375257 | chr11:16629289 | - | -0.051 | 8.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg01179137 | chr9:138090666 | - | -0.043 | 8.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg19579183 | chr11:59324467 | - | 0.037 | 9E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg00572089 | chr12:33750494 | - | -0.043 | 9.4E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg02607350 | chr7:5471691 | - | -0.073 | 9.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg14898787 | chr20:61729912 | HAR1B | -0.058 | 9.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg11443367 | chr11:132477294 | OPCML | 0.057 | 9.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg19934931 | chr9:95449336 | - | -0.055 | 9.5E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg11268178 | chr14:22881422 | - | -0.022 | 9.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg13067432 | chr1:58525635 | DAB1 | 0.042 | 9.6E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg11151544 | chr12:56135681 | GDF11 | -0.068 | 9.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg13736647 | chr5:126900956 | - | -0.061 | 9.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg17788595 | chr2:23254392 | - | -0.042 | 9.8E-05 |
| Robert F Hillary | 10.1101/2023.01.10.23284387 | DNA methylation | Prevalent Prostate Cancer (Self-report) | Whole blood | Fully-adjusted model | 6090 | cg10592926 | chr6:157876961 | ZDHHC14 | -0.044 | 9.8E-05 |
Download
*this tab-deliminated tsv file contains the full set of associations and variables, i.e. those in the downloadable catalog.
